NAD+ vs NMN: What’s the Difference in Cellular Energy Research?

Few molecules have attracted as much attention in ageing research as NAD+, and few comparisons are searched as often as “NAD vs NMN”. The two names appear side by side on supplement shelves, in podcasts and in headlines about longevity, and it is easy to assume they are rival versions of the same thing. They are related, but they are not the same. NAD+ is the working molecule inside every cell. NMN is one of the building blocks the cell uses to make it. Understanding that relationship, and what research has found about each, clears up most of the confusion.

This guide explains what NAD+ and NMN are, how they fit into the cell’s recycling system, what the key studies in animals and people found, how they compare with the other main precursor, NR, and what remains uncertain. It is an overview of research findings, not medical advice. Crown Peptides supplies NAD+ for laboratory research use only; we do not sell NMN.

The Short Answer

NAD+, nicotinamide adenine dinucleotide, is a coenzyme found in every living cell, essential for turning food into energy and consumed by enzymes that repair DNA and regulate ageing-related processes. Its levels decline with age in several tissues.

NMN, nicotinamide mononucleotide, is the molecule that sits one step before NAD+ in the cell’s main recycling pathway. Cells convert NMN into NAD+ in a single reaction. Researchers study NMN, and a related molecule called nicotinamide riboside, as ways of raising NAD+ levels by supplying its building blocks.

So the comparison is not really NAD+ versus NMN, but NAD+ itself versus one of its precursors.

A Short History of NAD+

A mysterious helper in yeast

NAD+ was discovered in 1906, when the British biochemists Arthur Harden and William John Young found that yeast extract needed a small, heat-stable “co-ferment” to ferment sugar. Hans von Euler-Chelpin later worked out much of its chemical nature, sharing the 1929 Nobel Prize in Chemistry with Harden. In the 1930s, Otto Warburg showed that the nicotinamide part of the molecule carries hydrogen in metabolic reactions, revealing how NAD+ actually works.

The vitamin connection

In 1937, Conrad Elvehjem at the University of Wisconsin showed that nicotinic acid, a form of vitamin B3, cured black tongue in dogs, a condition resembling the human disease pellagra. Pellagra, which causes skin inflammation, diarrhoea, dementia and death, was then common in populations relying heavily on maize. The cure was vitamin B3, the raw material for NAD+. Pellagra remains a vivid illustration of what happens when the body cannot make enough NAD+.

The ageing era

For most of the twentieth century, NAD+ was viewed as a housekeeping molecule of metabolism. That changed in 2000, when the sirtuin discovery linked it to ageing, and research in the 2010s showing age-related NAD+ decline and the effects of precursors in mice turned it into one of the most studied molecules in longevity science.

What NAD+ Does

The electron carrier

NAD+ is one of the most important molecules in all of biology. It picks up electrons during the breakdown of sugars and fats, becoming NADH, and delivers them to the mitochondria, where they are used to produce ATP, the cell’s energy currency. Without NAD+, energy metabolism grinds to a halt.

Fuel for sirtuins

NAD+ is also consumed as fuel by sirtuins, a family of enzymes that regulate metabolism, stress responses and gene activity. The link was established in 2000, when Imai, Guarente and colleagues showed in Nature that the yeast longevity protein Sir2 is an NAD-dependent enzyme (PMID: 10693811). That discovery tied the cell’s energy state directly to processes linked to lifespan.

Fuel for DNA repair

PARP enzymes use NAD+ to repair damaged DNA. When DNA damage is heavy, PARPs can consume large amounts of NAD+.

Consumed by CD38

The enzyme CD38, found on immune cells and others, also breaks down NAD+. A 2016 Mayo Clinic study in Cell Metabolism found that CD38 increases with age and is a major driver of age-related NAD+ decline (PMID: 27304511, PMC4911708).

The ageing connection

A 2014 review in Trends in Cell Biology by Imai and Guarente described declining NAD+ as a possible “Achilles’ heel” of ageing, summarising research in which restoring NAD+ improved age-associated defects in animal models (PMID: 24786309, PMC4112140). A 2021 review in Nature Reviews Molecular Cell Biology by Covarrubias, Verdin and colleagues set out the full picture of NAD+ metabolism and its roles in ageing (PMID: 33353981, PMC7963035).

How Cells Make NAD+

Three routes

Cells can make NAD+ from scratch from the amino acid tryptophan, from nicotinic acid, a form of vitamin B3, or, most importantly, by recycling nicotinamide through the salvage pathway.

The salvage pathway

Every time a sirtuin, PARP or CD38 consumes NAD+, it releases nicotinamide. The enzyme NAMPT converts nicotinamide into NMN, and a second enzyme, NMNAT, converts NMN into NAD+. This loop recycles most of the cell’s NAD+, and NAMPT is its rate-limiting step, meaning it controls how fast the loop can run.

Where NMN fits

NMN is the product of that rate-limiting step. Supplying NMN therefore bypasses NAMPT and feeds directly into the final step of NAD+ production. That is the core logic behind NMN research.

And nicotinamide riboside

Nicotinamide riboside, or NR, is another precursor. Cells convert it to NMN using enzymes called NRKs, and then to NAD+. NR and NMN are therefore one step apart in the same pathway.

The Full Precursor Landscape

NMN is only one of several molecules that can feed NAD+ production, and it helps to see them together.

Tryptophan

An essential amino acid from protein-rich food, converted to NAD+ through a long pathway mainly in the liver.

Nicotinic acid (niacin)

A form of vitamin B3, used in the Preiss-Handler pathway. At high amounts it causes flushing and has been used medically to alter blood fats.

Nicotinamide

Another form of vitamin B3 and the main substrate of the salvage pathway, recycled through NAMPT.

Nicotinamide riboside (NR)

Converted to NMN by NRK enzymes, then to NAD+.

NMN

Converted directly to NAD+ by NMNAT enzymes.

Reduced forms

Newer research has examined reduced forms such as NMNH and NRH, which may raise NAD+ through different routes. These are at an early stage.

NAD+ and the Body Clock

NAD+ levels are not constant through the day. Research in 2009 showed that NAMPT, the rate-limiting enzyme of the salvage pathway, is controlled by the circadian clock, so NAD+ rises and falls in a daily rhythm. In turn, NAD+-dependent sirtuins help regulate the clock itself. This two-way link between metabolism and daily rhythm means that the timing of measurements, and potentially of interventions, matters in NAD+ research. It also connects NAD+ research to sleep and circadian research.

What NMN Research Has Shown

Mice: slowing age-related decline

In a landmark 2016 study in Cell Metabolism, Mills, Imai and colleagues gave mice NMN in their drinking water from 5 to 17 months of age, a long period of their life (PMID: 28068222, PMC5668137). NMN was quickly used to make NAD+ in tissues, and it mitigated several age-associated changes, including weight gain, reduced energy metabolism, declining physical activity, worsening insulin sensitivity and changes in eye function and bone density, without obvious toxicity in the mice.

People: muscle insulin sensitivity

In a 2021 randomised, placebo-controlled trial published in Science, Yoshino, Klein, Imai and colleagues at Washington University gave NMN or placebo to postmenopausal women with prediabetes and overweight or obesity for 10 weeks (PMID: 33888596, PMC8550608). NMN increased muscle insulin sensitivity and insulin signalling, and changed the activity of genes related to muscle remodelling. It was one of the first controlled human trials to show a metabolic effect of an NAD+ precursor. It was small, involved a specific group of people and ran for 10 weeks, so its findings cannot be generalised broadly.

How NMN gets into cells

A long-running question was whether NMN enters cells directly or must first be broken down to NR. In a 2019 study in Nature Metabolism, Grozio, Imai and colleagues identified Slc12a8 as a transporter that carries NMN into cells in the mouse gut, and found that its levels rise in ageing gut tissue (PMID: 31131364, PMC6530925). The finding remains debated, and it is likely that both direct transport and conversion to NR contribute in different tissues.

What NR Research Has Shown

NR has its own human research. In a 2018 randomised, placebo-controlled crossover trial in Nature Communications, Martens, Seals and colleagues gave healthy middle-aged and older adults NR or placebo for six weeks (PMID: 29599478, PMC5876407). NR was well tolerated and increased NAD+ metabolism in blood cells, and the researchers reported signs of possible effects on blood pressure and arterial stiffness that warranted further study.

NAD+ vs NMN vs NR: The Key Differences

Position in the pathway

NR is converted to NMN, and NMN is converted to NAD+. NAD+ is the end product that the cell actually uses.

Size and cell entry

NAD+ is a relatively large molecule. Whether cells can take it up intact from outside has been debated, and much evidence suggests it is often broken down to smaller precursors, such as NMN or NR, outside cells before being rebuilt inside. NMN and NR are smaller and more readily handled by cells.

Human evidence

NR and NMN both have small randomised human trials showing that they raise NAD+ metabolism, and NMN has a trial showing improved muscle insulin sensitivity in a specific group. Human trials of NAD+ itself given directly are more limited.

Research use

In the laboratory, NAD+ is used when researchers want to supply the end product directly, for example in cell and enzyme studies, or to test what happens when NAD+ is available outside cells. NMN and NR are used to study how precursors feed the salvage pathway.

Other Ways to Raise NAD+

Supplying precursors is only one strategy. Researchers also study reducing NAD+ consumption, for example by inhibiting CD38, and protecting the precursor supply. 5-Amino-1MQ inhibits NNMT, an enzyme that removes nicotinamide from the salvage loop by attaching a methyl group to it. A 2014 study in Nature found that reducing NNMT raised NAD+ in fat tissue and protected mice against diet-induced obesity (PMID: 24717514, PMC4107212). Exercise and calorie restriction also influence NAD+ metabolism, and the mitochondrial peptide MOTS-c acts on related energy-sensing pathways.

NAD+ and Exercise

Exercise is one of the most reliable ways to influence NAD+ metabolism. Endurance training increases NAMPT in muscle, boosting the salvage pathway, and exercise activates AMPK and sirtuins, which depend on NAD+. Studies have found that people who exercise regularly tend to have higher muscle NAMPT than sedentary people. That makes exercise both a benchmark for NAD+ research and a potential confounding factor: any study of NAD+ precursors needs to account for how active the animals or participants are.

NAD+ in the Brain

Neurons are among the most energy-hungry cells in the body, and they depend on NAD+ for energy production and DNA repair. Research in animal models has linked NAD+ decline to changes in brain ageing and to models of neurodegeneration, and NAD+ precursors have been studied in those models. The brain is also protected by the blood-brain barrier, which influences which precursors can reach it. Brain NAD+ research is an active area, and it connects this topic to our brain research guide.

Why Mouse Results Are Hard to Translate

The NMN study in ageing mice produced a broad range of benefits, but human trials have so far found narrower effects. Several reasons may explain this. Mice have much faster metabolisms than people, and they break down precursors differently. Laboratory mice live in controlled conditions with standard diets. Human trials have been short and small, and have often enrolled relatively healthy people, in whom there may be less room for improvement. And the amounts that can be given to mice relative to body weight are often much larger than those used in people. None of this means the mouse results are wrong, only that translating them requires careful human research.

What Remains Uncertain

Do precursors reach every tissue?

Different tissues handle precursors differently, and raising NAD+ in blood does not guarantee raising it in muscle, brain or other organs to the same extent.

How much is enough?

It is not known what level of NAD+ restoration is needed to produce meaningful effects in people, or whether more is always better.

Long-term effects

Human trials so far have been short. Long-term effects, including whether raising NAD+ could influence processes such as cell growth in any setting, are not established.

Mice versus people

The dramatic effects seen in ageing mice have not yet been matched by comparably broad effects in human trials, which have tended to find more modest, specific changes.

Where NAD+ Declines, and Where It May Not

Age-related NAD+ decline has been reported in several tissues in animals, including liver, muscle, fat and brain, and in some human tissues such as skin and muscle. But the size of the decline varies between tissues, between studies and between measurement methods, and not every study has found it in every tissue. Blood measurements do not always reflect tissue levels. That variability is one reason researchers emphasise measuring NAD+ in the tissue of interest, and one reason results from different studies can be hard to compare.

NAD+ and Other Research Compounds

NAD+ connects to several other compounds studied in cellular energy and ageing research. SS-31 protects the inner mitochondrial membrane where NADH delivers its electrons. MOTS-c activates AMPK, which works closely with the NAD+-dependent sirtuins. Glutathione depends on NADPH, made from NAD+, for its recycling. And Epitalon is studied for telomeres, which are maintained partly with the help of NAD+-consuming PARP enzymes. Studying NAD+ alongside these compounds lets researchers explore how different parts of cellular energy and maintenance interact.

What a Good NAD+ Study Looks Like

The strongest NAD+ studies share several features. They state clearly which molecule was supplied and in what form. They measure NAD+ and related metabolites in the tissue of interest, using sensitive methods and rapid sample processing. They include a functional readout linked to a specific mechanism, such as insulin sensitivity, mitochondrial respiration or sirtuin activity. They control for diet, activity and time of day. And they use verified material, because degraded NAD+ or precursors can produce misleading results. The 2021 NMN trial in Science, with its placebo control, muscle biopsies and insulin clamp measurements, is a good example of this standard.

Designing NAD+ Research

Measure the whole metabolome

NAD+ exists in a network with NADH, NADP+, NADPH, nicotinamide, NMN, NR and their breakdown products. Measuring several of these, ideally by mass spectrometry, gives a far clearer picture than measuring NAD+ alone.

Measure in the right tissue

Because tissues differ, researchers should measure NAD+ where the effect is expected, such as muscle in the insulin sensitivity trial, not only in blood.

Link to function

Changes in NAD+ are most meaningful alongside functional measures, such as insulin sensitivity, mitochondrial respiration, physical performance or sirtuin activity.

Handle carefully

NAD+ and its precursors can break down in solution and in samples, so fresh preparation and rapid sample processing matter.

Common Pitfalls in NAD+ Research

NAD+ research has some particular traps. NAD+ and NADH break down quickly after samples are taken, so slow processing can produce misleadingly low values. Different measurement methods, such as enzyme-based assays and mass spectrometry, can give different results. Raising a precursor in the blood does not prove that NAD+ rose in the target tissue. And because NAD+ is involved in so many processes, it can be hard to know which of its roles is responsible for an effect. Careful designs use rapid sample handling, mass spectrometry, tissue-specific measurement and functional readouts that point to a specific mechanism, such as sirtuin activity.

The Technical Breakdown: The Chemistry of the NAD+ Family

Structure

NAD+ consists of two nucleotides joined through their phosphate groups: one carrying nicotinamide and one carrying adenine. NMN is the nicotinamide half, a single nucleotide. NR is NMN without its phosphate group. That is why NR needs one extra step, phosphorylation, to become NMN.

Redox chemistry

The nicotinamide ring is where the chemistry happens. It accepts a hydride, a hydrogen with two electrons, to become NADH, and gives it up again in the mitochondria. The ratio of NAD+ to NADH reflects the cell’s metabolic state.

Extracellular NAD+

Outside cells, NAD+ can be broken down by enzymes such as CD38 and CD73 into NMN and NR, which can then enter cells. This helps explain why supplying NAD+ outside cells can still raise NAD+ inside them indirectly.

NADPH

NAD+ can be converted to NADP+, whose reduced form, NADPH, powers antioxidant defences, including the recycling of glutathione. The NAD+ system therefore connects energy metabolism to antioxidant protection.

Why Quality Matters

NAD+ is sensitive to heat, light and moisture, and degraded material contains breakdown products such as nicotinamide and ADP-ribose that can influence results. Every batch of NAD+ supplied by Crown Peptides comes with a batch-specific certificate of analysis showing HPLC purity and mass spectrometry identity. Published certificates are on our Lab Reports page, and our guides to testing and storage cover the practical side. Larger quantities, including multi-vial packs, are available on the NAD+ product page.

Related Reading

Read our NAD+ guide, NAD+ vs MOTS-c, Epitalon vs NAD+ and best peptides for longevity research. Related compounds include SS-31, Glutathione and L-Carnitine, and the ageing and cellular research peptides category.

NAD+ vs NMN: Questions, Answered

What is the difference between NAD+ and NMN?

NAD+ is the working coenzyme inside cells. NMN is its immediate precursor, converted into NAD+ in a single step.

Which is better, NAD+ or NMN?

They serve different purposes in research. NAD+ supplies the end product directly; NMN feeds the cell’s own production pathway. Human evidence exists for NMN and NR in small trials, but neither has been shown to be broadly superior.

What is NR, and how does it differ?

Nicotinamide riboside, another NAD+ precursor, converted to NMN and then to NAD+.

Does NAD+ decline with age?

Research indicates NAD+ levels decline with age in several tissues, driven partly by increasing activity of the NAD-consuming enzyme CD38.

Can NAD+ precursors be combined with other approaches?

Yes. Researchers study precursors alongside NNMT inhibitors such as 5-Amino-1MQ, CD38 inhibitors, exercise and mitochondrial compounds, because each targets a different part of NAD+ metabolism. The clearest designs test each approach alone as well as together, so that any interaction between them can be measured.

What does NAMPT do?

NAMPT is the rate-limiting enzyme of the salvage pathway, converting nicotinamide into NMN. It controls how fast cells can recycle NAD+, and its activity follows the body clock and increases with exercise.

What is CD38?

An enzyme that breaks down NAD+. Research has found it increases with age and is a major driver of age-related NAD+ decline.

Where can I read the studies?

Every study in this guide is linked to its PubMed record.

Can NAD+ be measured in blood?

Yes, but blood levels do not always reflect levels in tissues such as muscle or brain, which is why researchers measure in the tissue of interest where possible.

Why do human NMN trials show smaller effects than mouse studies?

Possible reasons include differences in metabolism, study length, the health of participants and the amounts used. Larger, longer human trials are needed.

Is NAD+ exactly the same as vitamin B3?

No. Vitamin B3, in its forms nicotinic acid and nicotinamide, is a raw material the body uses to make NAD+.

What is pellagra?

A disease caused by deficiency of vitamin B3, the raw material for NAD+, causing skin inflammation, diarrhoea and dementia. It shows what happens when the body cannot make enough NAD+.

Does NAD+ follow a daily rhythm?

Yes. The enzyme NAMPT is controlled by the body clock, so NAD+ levels rise and fall through the day.

Does Crown Peptides sell NMN?

No. Crown Peptides supplies NAD+ itself for laboratory research.

Is NMN a peptide?

No. NMN and NAD+ are nucleotides, not peptides. They are supplied alongside peptides because they are used in the same research areas.

One Molecule, Many Doorways

NAD+ sits at the centre of cellular energy, DNA repair and the enzymes that link metabolism to ageing. NMN and NR are doorways into making more of it, NNMT inhibitors protect its supply, and CD38 inhibitors slow its loss. The research so far is compelling in mice and promising but modest in people. For researchers, the key is to choose the doorway that fits the question being asked, to measure the whole NAD+ network in the right tissue rather than a single molecule in the blood, and to link every change in NAD+ to a meaningful change in function, so that the results show not just that NAD+ moved, but what that movement actually did.

Explore NAD+ from Crown Peptides, every batch HPLC and mass spectrometry verified and dispatched from the UK.